Search research articles
Contact Us
Filters
Showing results (91-100 of 242) with videos related to
Page
of 25
Sort By:
Lancet (London, England)
|
March 31, 1973
Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer
A J Edwards, G F Rowland, M R Lee
Archives of Disease in Childhood
|
January 1, 1978
Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors
J M Littlewood, M R Lee, S R Meadow
Lancet (London, England)
|
October 9, 1976
Treatment of childhood Bartter's syndrome with indomethacin
J M Littlewood, M R Lee, S R Meadow
Clinical Science (London, England : 1979)
|
January 1, 1988
A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man
R F Jeffrey, T M MacDonald, M R Lee
Scottish Medical Journal
|
December 1, 1987
Methaemoglobinaemia produced by phenazopyridine (Pyridium) in a man with chronic obstructive airways disease
T K Chakraborty, R J Filshie, M R Lee
Applied and Environmental Microbiology
|
September 1, 1992
Topical application of ice-nucleating-active bacteria decreases insect cold tolerance
J M Strong-Gunderson, R E Lee, M R Lee
Journal of Molecular Biology
|
January 22, 2002
Molecular dynamics in the endgame of protein structure prediction
M R Lee, J Tsai, D Baker, et al.
Clinical Physiology and Biochemistry
|
January 1, 1986
Urine dopamine in starving obese subjects
R Swaminathan, G Cope, J K Wales, et al.
American Journal of Hypertension
|
June 1, 1990
Effect of prolonged intravenous infusion of gludopa in humans and a preliminary study of its oral bioavailability
S Freestone, R Ellis, T M MacDonald, et al.
Clinical Science (London, England : 1979)
|
August 1, 1985
gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects
D P Worth, J N Harvey, J Brown, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 242) with videos related to
Sort By:
Page
of 25
Lancet (London, England)
|
March 31, 1973
Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer
A J Edwards, G F Rowland, M R Lee
Archives of Disease in Childhood
|
January 1, 1978
Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors
J M Littlewood, M R Lee, S R Meadow
Lancet (London, England)
|
October 9, 1976
Treatment of childhood Bartter's syndrome with indomethacin
J M Littlewood, M R Lee, S R Meadow
Clinical Science (London, England : 1979)
|
January 1, 1988
A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man
R F Jeffrey, T M MacDonald, M R Lee
Scottish Medical Journal
|
December 1, 1987
Methaemoglobinaemia produced by phenazopyridine (Pyridium) in a man with chronic obstructive airways disease
T K Chakraborty, R J Filshie, M R Lee
Applied and Environmental Microbiology
|
September 1, 1992
Topical application of ice-nucleating-active bacteria decreases insect cold tolerance
J M Strong-Gunderson, R E Lee, M R Lee
Journal of Molecular Biology
|
January 22, 2002
Molecular dynamics in the endgame of protein structure prediction
M R Lee, J Tsai, D Baker, et al.
Clinical Physiology and Biochemistry
|
January 1, 1986
Urine dopamine in starving obese subjects
R Swaminathan, G Cope, J K Wales, et al.
American Journal of Hypertension
|
June 1, 1990
Effect of prolonged intravenous infusion of gludopa in humans and a preliminary study of its oral bioavailability
S Freestone, R Ellis, T M MacDonald, et al.
Clinical Science (London, England : 1979)
|
August 1, 1985
gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects
D P Worth, J N Harvey, J Brown, et al.
Page
of 25